Mednet Logo
CommunityNeurology

How do you decide on switching to a different preventative anti-CGRP treatment in migraine patients who are experiencing reduced effectiveness with their current treatment?

Is there a point of diminishing returns after switching between multiple anti-CGRP treatments?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Neurology · Greater Boston Headache Center at Boston Advanced Medicine
Answered on · Updated on

The CGRP antibodies and gepants are my preventive treatments of choice. In fact, I hardly ever prescribe anything else anymore preventively, including botulinum toxin. Tolerability issues I hardly ever encounter with the antibodies, but sometimes I do with the gepants, in particular fat...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Neurology · Wellspan Health
Answered on

On occasion, I have found that patients who were diagnosed with chronic migraine actually have EPH or CPH and respond to an indomethacin trial. Alternatively, those with less-than-ideal responses to CGRP antagonists or gepants, Botox injections can offer more relief. These patients tend to have a si...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · UPMC
Answered on

If we have not achieved a desired efficacy, such as >50% improvement in headache frequency and/or frequency of severe headaches, or a patient perceives that a migraine disorder still significantly impacts the quality of life, I switch between different anti-CGRP treatments. I try at lea...

Join for free or sign in to see the full answer